GC74055
MyoMed 205
Also known as 4-[(4-methyl-2-oxochromen-7-yl)oxymethyl]-N-[2-(thiophen-2-ylmethylcarbamoylamino)ethyl]benzamide
MyoMed-205 is an inhibitor targeting the activity of MuRF1
ChemicalCAS2614161-13-4MW491.56FormulaC26H25N3O5S
- CAS number
- 2614161-13-4
- Molecular weight
- 491.56
- Formula
- C26H25N3O5S
- Solubility
- DMSO ： 25 mg/mL (50·86 mM; ultrasonic and warming and heat to 60°C)
- InChIKey
- JPPDUCIRFIVCPH-UHFFFAOYSA-N
- Catalogue number
- GC74055
- Brand
- GLPBIO
Computed properties PubChem CID 156094542 · XLogP 2.9 · TPSA 134 Ų · H-bond donors 3
- XLogP
- 2.9
- TPSA
- 134 Ų
- H-bond donors
- 3
- H-bond acceptors
- 6
- Rotatable bonds
- 9
- Heavy atoms
- 35
SMILES CC1=CC(=O)OC2=C1C=CC(=C2)OCC3=CC=C(C=C3)C(=O)NCCNC(=O)NCC4=CC=CS4
Computed descriptors from PubChem (CID 156094542), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il